Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grottoli

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Journal of Endocrinological Investigation|May 29, 2024
Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly managementS Grottoli, P Maffei, A S Tresoldi, et al.
Journal of Endocrinological Investigation|November 19, 1997
Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in manM Maccario, S E Oleandri, M Procopio, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucoseM Maccario, M Procopio, S Grottoli, et al.
Journal of Endocrinological Investigation|February 11, 2012
The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditionsM Filopanti, C Giavoli, S Grottoli, et al.
Journal of Endocrinological Investigation|August 24, 2019
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational studyV Gasco, L Roncoroni, M Zavattaro, et al.
Clinical Endocrinology|December 1, 1995
Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginineM Procopio, M Maccario, S Grottoli, et al.
Clinical Endocrinology|January 1, 1996
Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patientsE Ciccarelli, S Grottoli, P Razzore, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 1, 1996
Human aging and the GH-IGF-I axisE Ghigo, E Arvat, L Gianotti, et al.
Journal of Endocrinological Investigation|January 2, 2003
Age-related endocrine and metabolic changes in simple obesityF Tassone, R Rossetto, C Gauna, et al.
Journal of Endocrinological Investigation|July 12, 2002
Glucagon administration elicits blunted GH but exaggerated ACTH response in obesityF Tassone, S Grottoli, R Rossetto, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Journal of Endocrinological Investigation|May 29, 2024
Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly managementS Grottoli, P Maffei, A S Tresoldi, et al.
Journal of Endocrinological Investigation|November 19, 1997
Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in manM Maccario, S E Oleandri, M Procopio, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucoseM Maccario, M Procopio, S Grottoli, et al.
Journal of Endocrinological Investigation|February 11, 2012
The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditionsM Filopanti, C Giavoli, S Grottoli, et al.
Journal of Endocrinological Investigation|August 24, 2019
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational studyV Gasco, L Roncoroni, M Zavattaro, et al.
Clinical Endocrinology|December 1, 1995
Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginineM Procopio, M Maccario, S Grottoli, et al.
Clinical Endocrinology|January 1, 1996
Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patientsE Ciccarelli, S Grottoli, P Razzore, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 1, 1996
Human aging and the GH-IGF-I axisE Ghigo, E Arvat, L Gianotti, et al.
Journal of Endocrinological Investigation|January 2, 2003
Age-related endocrine and metabolic changes in simple obesityF Tassone, R Rossetto, C Gauna, et al.
Journal of Endocrinological Investigation|July 12, 2002
Glucagon administration elicits blunted GH but exaggerated ACTH response in obesityF Tassone, S Grottoli, R Rossetto, et al.
Pageof 13